Grifols SA
OTC:GIFOF
Grifols SA
OTC:GIFOF
Price:
8.2
USD
Market Closed
Market Cap:
$5.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Grifols SA
OTC:GIFOF
|
ES |
|
Zodiac Clothing Company Ltd
NSE:ZODIACLOTH
|
IN |
|
Beijing Scitop Bio-tech Co Ltd
SZSE:300858
|
CN |
|
Covenant Logistics Group Inc
NYSE:CVLG
|
US |
|
P
|
Petsec Energy Ltd
ASX:PSA
|
AU |
|
Concentradora Fibra Danhos SA de CV
BMV:DANHOS13
|
MX |
|
A
|
Alma Media Oyj
LSE:0DJN
|
FI |
|
Deutsche Real Estate AG
F:DRE2
|
DE |
|
First Resources Ltd
SGX:EB5
|
SG |
|
Gecina SA
PAR:GFC
|
FR |
|
S
|
STCube Inc
KOSDAQ:052020
|
KR |
|
Champion Electric Metals Inc
OTC:CHELF
|
CA |
Multiples-Based Value
The
Multiples-Based Value for
Grifols SA (GIFOF)
under the Base Case is
hidden
USD.
Compared with the current market price of 8.2 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GIFOF Multiples-Based Value
LOCKED
Multiples Across Competitors
GIFOF Competitors Multiples
Grifols SA Competitors
Grifols SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Grifols SA
OTC:GIFOF
|
6.4B USD | 0.9 | 16 | 8.2 | 11.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.3 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.6 | 17.7 | 13.1 | 15 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 12.4 | 39.7 | 43.1 | 44 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 3 | 32.9 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
